Deep TMS (transcranial magnetic stimulation) is a noninvasive technique used to apply brief magnetic pulses to the brain. Brainsway is testing the technology in treating various psychological and neurological conditions, such as schizophrenia, depression, and Alzheimer's disease.
The new Be'er Ya'akov study will follow 90-102 patients.
Shares in Brainsway rose 2.37% to NIS 13.41 on the Tel Aviv Stock Exchange (TASE) today.
You comment was recieved and soon will be published.
Thank you for posting your comment, which will be reviewed for publication.
Load more comments